Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Lombard Medical, Inc. stock logo
EVARF
Lombard Medical
$0.00
$0.00
$0.00
N/AN/AN/AN/A
Presbia PLC stock logo
LENS
Presbia
$0.15
$0.23
$5.50
$258K2.57122,366 shsN/A
Nuvectra Corp stock logo
NVTRQ
Nuvectra
$0.02
-25.0%
$0.02
$0.01
$4.30
N/AN/AN/A382,600 shs
OCLG
Oncologix Tech
$0.00
$0.00
$0.00
$0.00
N/A1.61360,319 shsN/A
Valeritas Holdings, Inc. stock logo
VLRXQ
Valeritas
$0.02
$0.02
$0.01
$4.28
N/AN/AN/AN/A
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Lombard Medical, Inc. stock logo
EVARF
Lombard Medical
0.00%0.00%0.00%0.00%0.00%
Presbia PLC stock logo
LENS
Presbia
0.00%0.00%0.00%0.00%0.00%
Nuvectra Corp stock logo
NVTRQ
Nuvectra
0.00%0.00%0.00%0.00%0.00%
OCLG
Oncologix Tech
0.00%0.00%+100.00%+100.00%-80.00%
Valeritas Holdings, Inc. stock logo
VLRXQ
Valeritas
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Lombard Medical, Inc. stock logo
EVARF
Lombard Medical
N/AN/AN/AN/AN/AN/AN/AN/A
Presbia PLC stock logo
LENS
Presbia
N/AN/AN/AN/AN/AN/AN/AN/A
Nuvectra Corp stock logo
NVTRQ
Nuvectra
N/AN/AN/AN/AN/AN/AN/AN/A
OCLG
Oncologix Tech
N/AN/AN/AN/AN/AN/AN/AN/A
Valeritas Holdings, Inc. stock logo
VLRXQ
Valeritas
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Lombard Medical, Inc. stock logo
EVARF
Lombard Medical
N/AN/AN/AN/A
Presbia PLC stock logo
LENS
Presbia
N/AN/AN/AN/A
Nuvectra Corp stock logo
NVTRQ
Nuvectra
N/AN/AN/AN/A
OCLG
Oncologix Tech
N/AN/AN/AN/A
Valeritas Holdings, Inc. stock logo
VLRXQ
Valeritas
N/AN/AN/AN/A

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Lombard Medical, Inc. stock logo
EVARF
Lombard Medical
N/AN/AN/AN/AN/AN/A
Presbia PLC stock logo
LENS
Presbia
$20K0.00N/AN/A$0.09 per share0.00
Nuvectra Corp stock logo
NVTRQ
Nuvectra
N/AN/AN/AN/AN/AN/A
OCLG
Oncologix Tech
N/AN/AN/AN/AN/AN/A
Valeritas Holdings, Inc. stock logo
VLRXQ
Valeritas
N/AN/AN/AN/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Lombard Medical, Inc. stock logo
EVARF
Lombard Medical
N/AN/A0.00N/AN/AN/AN/AN/AN/A
Presbia PLC stock logo
LENS
Presbia
-$8.41MN/A0.00N/AN/A-36,604.35%-414.02%-195.56%N/A
Nuvectra Corp stock logo
NVTRQ
Nuvectra
N/AN/A0.00N/AN/AN/AN/AN/A
OCLG
Oncologix Tech
N/AN/A0.00N/AN/AN/AN/AN/A
Valeritas Holdings, Inc. stock logo
VLRXQ
Valeritas
N/AN/A0.00N/AN/AN/AN/AN/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Lombard Medical, Inc. stock logo
EVARF
Lombard Medical
N/AN/AN/AN/AN/A
Presbia PLC stock logo
LENS
Presbia
N/AN/AN/AN/AN/A
Nuvectra Corp stock logo
NVTRQ
Nuvectra
N/AN/AN/AN/AN/A
OCLG
Oncologix Tech
N/AN/AN/AN/AN/A
Valeritas Holdings, Inc. stock logo
VLRXQ
Valeritas
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Lombard Medical, Inc. stock logo
EVARF
Lombard Medical
N/AN/AN/A
Presbia PLC stock logo
LENS
Presbia
1.24
2.88
2.82
Nuvectra Corp stock logo
NVTRQ
Nuvectra
N/AN/AN/A
OCLG
Oncologix Tech
N/AN/AN/A
Valeritas Holdings, Inc. stock logo
VLRXQ
Valeritas
N/AN/AN/A

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Lombard Medical, Inc. stock logo
EVARF
Lombard Medical
N/A
Presbia PLC stock logo
LENS
Presbia
16.42%
Nuvectra Corp stock logo
NVTRQ
Nuvectra
N/A
OCLG
Oncologix Tech
N/A
Valeritas Holdings, Inc. stock logo
VLRXQ
Valeritas
N/A

Insider Ownership

CompanyInsider Ownership
Lombard Medical, Inc. stock logo
EVARF
Lombard Medical
N/A
Presbia PLC stock logo
LENS
Presbia
74.20%
Nuvectra Corp stock logo
NVTRQ
Nuvectra
2.90%
OCLG
Oncologix Tech
39.90%
Valeritas Holdings, Inc. stock logo
VLRXQ
Valeritas
1.02%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Lombard Medical, Inc. stock logo
EVARF
Lombard Medical
113N/AN/ANot Optionable
Presbia PLC stock logo
LENS
Presbia
2417.23 millionN/ANot Optionable
Nuvectra Corp stock logo
NVTRQ
Nuvectra
197N/AN/ANot Optionable
OCLG
Oncologix Tech
191N/AN/ANot Optionable
Valeritas Holdings, Inc. stock logo
VLRXQ
Valeritas
125N/AN/ANot Optionable

LENS, VLRXQ, NVTRQ, EVARF, and OCLG Headlines

SourceHeadline
Individualizing Targets and Tactics for High-Risk Patients With Type 2 DiabetesIndividualizing Targets and Tactics for High-Risk Patients With Type 2 Diabetes
medscape.com - February 15 at 2:26 PM
Valeritas Holdings Inc (VLRXQ)Valeritas Holdings Inc (VLRXQ)
investing.com - June 20 at 10:41 PM
Vaccines Delivery Devices Market – A Comprehensive Study by Key ... - StreetBuzzVaccines Delivery Devices Market – A Comprehensive Study by Key ... - StreetBuzz
news.google.com - May 14 at 1:36 AM
Microneedle Drug Delivery Systems Market Incredible Possibilities ... - StreetBuzzMicroneedle Drug Delivery Systems Market Incredible Possibilities ... - StreetBuzz
news.google.com - May 13 at 12:25 AM
Microneedle-based Drug Delivery System Market – A ... - StreetBuzzMicroneedle-based Drug Delivery System Market – A ... - StreetBuzz
news.google.com - May 12 at 2:25 PM
Liquid-based Needle-Free Injector Market Scope, Trends, Growth ... - Taiwan NewsLiquid-based Needle-Free Injector Market Scope, Trends, Growth ... - Taiwan News
news.google.com - May 12 at 2:25 PM
Diabetes Devices Market Business Strategies and Massive Demand ... - Cottonwood Holladay JournalDiabetes Devices Market Business Strategies and Massive Demand ... - Cottonwood Holladay Journal
news.google.com - May 11 at 8:22 AM
Wearable Injectors Market Research & Advancements by 2028 ... - Cottonwood Holladay JournalWearable Injectors Market Research & Advancements by 2028 ... - Cottonwood Holladay Journal
news.google.com - May 11 at 8:22 AM
Diabetes Devices Market Size, Trends, Share, Growth and Forecast ... - Cottonwood Holladay JournalDiabetes Devices Market Size, Trends, Share, Growth and Forecast ... - Cottonwood Holladay Journal
news.google.com - May 11 at 8:22 AM
Medical Insulin Pumps Market 2023 – Top Manufacturers, Latest ... - Cottonwood Holladay JournalMedical Insulin Pumps Market 2023 – Top Manufacturers, Latest ... - Cottonwood Holladay Journal
news.google.com - May 11 at 8:22 AM
Infusion Pump Market Estimated to Reach USD 27.03 Billion by ... - Digital JournalInfusion Pump Market Estimated to Reach USD 27.03 Billion by ... - Digital Journal
news.google.com - May 11 at 8:22 AM
Insulin Pump Market Estimated to Reach USD 18.15 Billion by 2030 ... - Digital JournalInsulin Pump Market Estimated to Reach USD 18.15 Billion by 2030 ... - Digital Journal
news.google.com - May 11 at 8:22 AM
Intramuscular Injector Market To Witness Huge Growth by 2030 | Edmund Healthcare, BD, Injex Pharma - openPRIntramuscular Injector Market To Witness Huge Growth by 2030 | Edmund Healthcare, BD, Injex Pharma - openPR
news.google.com - May 10 at 10:20 PM
Insulin Pump Market Growth, Analysis & Forecast to 2032 ... - Cottonwood Holladay JournalInsulin Pump Market Growth, Analysis & Forecast to 2032 ... - Cottonwood Holladay Journal
news.google.com - May 10 at 10:20 PM
Needle-Free Drug Delivery Devices Market | Exclusive Report on ... - Cottonwood Holladay JournalNeedle-Free Drug Delivery Devices Market | Exclusive Report on ... - Cottonwood Holladay Journal
news.google.com - May 10 at 10:20 PM
Insulin Delivery Pump Market 2023 Global analysis, opportunities ... - Taiwan NewsInsulin Delivery Pump Market 2023 Global analysis, opportunities ... - Taiwan News
news.google.com - May 10 at 7:18 AM
Disposable Insulin-Delivery Device Market Size 2022 to 2032 | By ... - Future Market InsightsDisposable Insulin-Delivery Device Market Size 2022 to 2032 | By ... - Future Market Insights
news.google.com - May 9 at 6:01 AM
Global Smart Insulin Pens and Pumps Market to Reach $8.3 Billion by 2030 - Yahoo FinanceGlobal Smart Insulin Pens and Pumps Market to Reach $8.3 Billion by 2030 - Yahoo Finance
news.google.com - May 8 at 3:00 PM
Global Intramuscular Injector Market Size 2023, Growth Prospects ... - The Northwestern ExaminerGlobal Intramuscular Injector Market Size 2023, Growth Prospects ... - The Northwestern Examiner
news.google.com - May 8 at 3:00 PM
Global Smart Insulin Pens and Pumps Market to Reach $8.3 Billion ... - GlobeNewswireGlobal Smart Insulin Pens and Pumps Market to Reach $8.3 Billion ... - GlobeNewswire
news.google.com - May 8 at 9:59 AM
Insulin Pump Accessories Market 2031 Insights with Key Innovations ... - FylladeyInsulin Pump Accessories Market 2031 Insights with Key Innovations ... - Fylladey
news.google.com - May 7 at 9:25 AM
Tubeless Insulin Pump Market Research Report 2023-2031 to ... - The Northwestern ExaminerTubeless Insulin Pump Market Research Report 2023-2031 to ... - The Northwestern Examiner
news.google.com - May 7 at 4:24 AM
On-Body Injectors Market to Witness Comprehensive Growth 2023-2030| BD Medical, Medtronic, Insulet - openPROn-Body Injectors Market to Witness Comprehensive Growth 2023-2030| BD Medical, Medtronic, Insulet - openPR
news.google.com - May 7 at 4:24 AM
Microneedle Drug Delivery Systems Market: Opportunities ... - Digital JournalMicroneedle Drug Delivery Systems Market: Opportunities ... - Digital Journal
news.google.com - May 4 at 4:36 PM

Media Sentiment Over Time

Company Descriptions

Lombard Medical logo

Lombard Medical

OTCMKTS:EVARF
Lombard Medical, Inc., a medical technology company, develops, manufactures, and markets endovascular stent-grafts for the repair of aortic aneurysms in the United States, the United Kingdom, Germany, Japan, and internationally. The company's principal product is Aorfix, which is an endovascular stent-graft for the treatment of abdominal aortic aneurysms (AAAs) with angulation at the neck of the aneurysm of up to 90 degrees. Its products also include Altura endovascular stent graft system for the treatment of standard AAA anatomies; Aorflex delivery system for accurate placement of Aorfix in the abdominal aorta; and IntelliFlex LP delivery system that enhances the precision and control of Aorfix deployment and placement. Lombard Medical, Inc. sells its products directly through its direct sales force and distributors to state-or-government-owned hospitals. The company was founded in 2000 and is headquartered in Didcot, the United Kingdom.
Presbia logo

Presbia

NASDAQ:LENS
Presbia PLC is a holding company. It engages in the development and marketing of presbyopia-correcting solutions under the trademark of Presbia Flexivue Microlens. It operates through the Restoration of Clear Vision Caused by Presbyopia segment. The company was founded on February 2, 2014 and is headquartered in Dublin, Ireland.
Nuvectra logo

Nuvectra

OTCMKTS:NVTRQ
Nuvectra Corporation, a neurostimulation medical device company, develops and commercializes neurostimulation technology platform for the treatment of various disorders in neuroscience and clinical markets. The company offers Algovita, a spinal cord stimulation system for the treatment of chronic intractable pain of the trunk and limbs. It is also developing Virtis, a sacral neuromodulation (SNM) system for the treatment of chronic urinary retention and overactive bladder; and technologies to support other indications, including SNM for the treatment of overactive bladder and deep brain stimulation to treat Parkinson's disease. The company serves hospitals, surgery centers, and medical facilities through a direct sales force and third-party distributors in the United States and Europe. Nuvectra Corporation was founded in 2008 and is headquartered in Plano, Texas.

Oncologix Tech

OTCMKTS:OCLG
Oncologix Tech, Inc., a diversified medical holding company, provides health care services in the United States. It offers personal home care services, including daily living assistance, companionship, and homemaker services, as well as Alzheimer's care, home care resource planning, and medical care coordination services. The company also manufactures, markets, and distributes medical technologies and products for skilled nursing facilities, acute and critical care facilities, assisted living facilities, hospitals and medical institutions, federal agencies, home medical care industry, respiratory and therapy- physical/occupational therapy centers. In addition, it distributes and sells home medical equipment for sleep and respiratory therapies; supplies and services durable medical equipment to treat obstructive Sleep Apnea; C-PAP and BiPAP oxygen equipment, a large selection of mask interfaces; and offers personalized treatment plans, as well as monitoring and support services. The company was formerly known as BestNet Communications Corp. and changed its name to Oncologix Tech, Inc. in January 2007. Oncologix Tech, Inc. was founded in 1995 and is based in Lafayette, Louisiana.
Valeritas logo

Valeritas

OTCMKTS:VLRXQ
Valeritas Holdings, Inc., a commercial-stage medical technology company, focuses on the development and commercialization of technologies to treat patients with Type 2 diabetes in the United States. The company offers V-Go, a wearable insulin delivery device for basal-bolus therapy. It also develops V-Go Prefill that is in the design-development stage for eliminating the device-filling process and the need for EZ fill refrigeration for patients with Type 2 diabetes; and V-Go SIM for real-time tracking information of basal and bolus dosing utilization. The company sells V-Go to third-party wholesalers and medical supply distributors. Valeritas Holdings, Inc. was founded in 2006 and is headquartered in Bridgewater, New Jersey.